Agenus Shares Target Cut to $5, Analyst Maintains Buy Rating
Agenus Analyst Ratings
B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating
Agenus Analyst Ratings
Agenus's Promising Botensilimab Leads to Buy Rating From Analyst Mayank Mamtani
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY)
Positive Outlook for Agenus: Promising Clinical Progress and Effective Financial Management Drive Buy Rating
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)
B.Riley Financial Sticks to Its Buy Rating for Agenus (AGEN)
Agenus (AGEN) Receives a Buy From Robert W. Baird
B.Riley Financial Sticks to Their Buy Rating for Agenus (AGEN)
Robert W. Baird Keeps Their Buy Rating on Agenus (AGEN)
Analysts' Top Healthcare Picks: Organon (OGN), Agenus (AGEN)
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $8 Price Target
Agenus Analyst Ratings
Agenus (AGEN) Gets a Buy From H.C. Wainwright
Agenus (AGEN) Receives a Buy From Jefferies
B.Riley Financial Reaffirms Their Buy Rating on Agenus (AGEN)
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), CytomX Therapeutics (CTMX) and Bausch + Lomb Corporation (BLCO)
No Data